Logo do repositório
 
A carregar...
Miniatura
Publicação

Unlocking the role of metabolic pathways in brain metastatic disease

Utilize este identificador para referenciar este registo.
Nome:Descrição:Tamanho:Formato: 
Unlocking_role.pdf1.63 MBAdobe PDF Ver/Abrir

Orientador(es)

Resumo(s)

The dissemination of malignant cells to the brain is a late-stage complication of cancer, leading to significant morbidity and mortality. Brain metastases (BM) affect 20-30% of cancer patients, primarily originating from lung cancer, breast cancer, and melanoma. Despite advances in molecular-targeted therapies, brain metastatic disease remains incurable, with a poor median survival of ≤12 months if left untreated. The lack of therapeutic efficacy is mainly attributed to the presence of the blood-brain barrier (BBB) and genetic differences between BM and their primary tumors. Previously published data have identified potential driver mutations of BM. However, the mechanisms underlying brain cancer dissemination remain unknown. Recent studies emphasize the pivotal role of metabolic adaptations in supporting the metastatic process, particularly in the nutrient-poor microenvironment characteristic of the brain. Understanding the interplay between metabolism and genetic alterations associated with brain metastatic disease could unveil novel therapeutic targets that are more effective in treating patients. This review focuses on relevant metabolic pathways in cancer, particularly brain cancer dissemination, while also presenting information on current preclinical models of BM, relevant clinical trials, and preclinical studies targeting metabolic reprogramming, providing an overview for advancing therapeutic strategies in BM.

Descrição

© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Palavras-chave

Brain metastatic disease Cancer metabolism Metabolic reprogramming Therapeutic targets

Contexto Educativo

Citação

Cells. 2025 May 13;14(10):707

Projetos de investigação

Unidades organizacionais

Fascículo

Editora

MDPI

Licença CC

Métricas Alternativas